Literature DB >> 57616

Bovine leukemia virus: an exogenous RNA oncogenic virus.

R Kettmann, D Portetelle, M Mammerickx, Y Cleuter, D Dekegel, M Galoux, J Ghysdael, A Burny, H Chantrenne.   

Abstract

Short-term cultures of bovine leukemic lymphocytes release virus particles with biochemical properties of RNA oncogenic viruses. These particles, tentatively called bovine leukemia virus (BLV), have a high molecular weight RNA-reverse transcriptase complex and a density of 1.155 g/ml in sucrose solutions. Molecular hybridizations between BLV/[3H]cDNA and several viral RNAs show that BLV is not related to Mason-Pfizer monkey virus, simian sarcoma associated virus, feline leukemia virus, or avian myeloblastosis virus. These results were confirmed by hybridization between BLV 70S RNA and [3H]cDNA synthesized in the various viruses tested. The high preference of BLV reverse transciptase for Mg++ as the divalent cation suggests that BLV might be an atypical mammalian leukemogenic "type C" virus. DNA-DNA hybridization studies using BLV [3H]cDNA as a probe strongly suggest that the DNA of bovine leukemic cells contains viral sequences that cannot be detected in normal bovine DNA.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 57616      PMCID: PMC430190          DOI: 10.1073/pnas.73.4.1014

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Extent of transcription by the RNA-dependent DNA polymerase of Rous sarcoma virus.

Authors:  H E Varmus; W E Levinson; J M Bishop
Journal:  Nat New Biol       Date:  1971-09-01

2.  RNA-dependent DNA polymerase activity in five RNA viruses: divalent cation requirements.

Authors:  E Scolnick; E Rands; S A Aaronson; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1970-12       Impact factor: 11.205

3.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

4.  Characterization of the products of DNA-directed DNA polymerases in oncogenic RNA viruses.

Authors:  S Spiegelman; A Burny; M R Das; J Keydar; J Schlom; M Travnicek; K Watson
Journal:  Nature       Date:  1970-08-08       Impact factor: 49.962

5.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

6.  Comparative biochemical properties of RNA-directed DNA polymerases from Rauscher murine leukemia virus and avian myeloblastosis virus.

Authors:  L C Waters; W K Yang
Journal:  Cancer Res       Date:  1974-10       Impact factor: 12.701

7.  Structure of C-type virus particles in lymphocyte cultures of bovine origin.

Authors:  J Calafat; P C Hageman; A A Ressang
Journal:  J Natl Cancer Inst       Date:  1974-04       Impact factor: 13.506

8.  Viral-related DNA sequences before and after transformation by RNA tumor viruses.

Authors:  N C Goodman; R M Ruprecht; R W Sweet; R Massey; F Deinhardt; S Spiegelman
Journal:  Int J Cancer       Date:  1973-11-15       Impact factor: 7.396

9.  Purification, characterization, and comparison of the DNA polymerases from two primate RNA tumor viruses.

Authors:  J W Abrell; R C Gallo
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

10.  Leukemia-specific DNA sequences in leukocytes of the leukemic member of identical twins.

Authors:  W Baxt; J W Yates; H J Wallace; J F Holland; S Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

View more
  42 in total

1.  Proviral detection and serology in bovine leukemia virus-exposed normal cattle and cattle with lymphoma.

Authors:  R M Jacobs; Z Song; H Poon; J L Heeney; J A Taylor; B Jefferson; W Vernau; V E Valli
Journal:  Can J Vet Res       Date:  1992-10       Impact factor: 1.310

2.  Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus.

Authors:  D Pyeon; F J Diaz; G A Splitter
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Interleukin-12 p40 mRNA expression in bovine leukemia virus-infected animals: increase in alymphocytosis but decrease in persistent lymphocytosis.

Authors:  D Pyeon; G A Splitter
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

4.  The pX region of the bovine leukemia virus is transcribed as a 2.1-kilobase mRNA.

Authors:  R Z Mamoun; T Astier-Gin; R Kettmann; J Deschamps; N Rebeyrotte; B J Guillemain
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

5.  The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection.

Authors:  M L Mirsky; C A Olmstead; Y Da; H A Lewin
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

6.  Mason-Pfizer like virus in kidney grafted patients.

Authors:  L Thiry; S Sprecher-Goldberger; P Vandenbussche; M Bossens; P Vereerstraten; O Hestermans-Medard
Journal:  Med Microbiol Immunol       Date:  1979-01-24       Impact factor: 3.402

7.  Proteins of bovine leukemia virus. I. Characterization and reactions with natural antibodies.

Authors:  L Deshayes; D Levy; A L Parodi; J P Levy
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

8.  Frog oocytes synthesize and completely process the precursor polypeptide to virion structural proteins after microinjection of avian myeloblastosis virus RNA.

Authors:  J Ghysdael; E Hubert; M Trávnícek; D P Bolognesi; A Burny; Y Cleuter; G Huez; R Kettmann; G Marbaix; D Portetelle; H Chantrenne
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

9.  Epidemiological evaluation of a monoclonal ELISA detecting antibodies against bovine leukaemia virus in serum pools.

Authors:  K Knapen; P Kerkhofs; E Thiry; M Mammerickx
Journal:  Epidemiol Infect       Date:  1994-12       Impact factor: 2.451

10.  Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo.

Authors:  Jean-Stéphane Gatot; Isabelle Callebaut; Carine Van Lint; Dominique Demonté; Pierre Kerkhofs; Daniel Portetelle; Arsène Burny; Luc Willems; Richard Kettmann
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.